+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibodies"

Cancer Biologics Market 2026-2030 - Product Thumbnail Image

Cancer Biologics Market 2026-2030

  • Report
  • August 2026
  • 324 Pages
  • Global
From
Pd-1 and Pd-L1 Inhibitors Market 2026-2030 - Product Thumbnail Image

Pd-1 and Pd-L1 Inhibitors Market 2026-2030

  • Report
  • April 2026
  • 286 Pages
  • Global
From
Autoimmune Drugs Market 2026-2030 - Product Thumbnail Image

Autoimmune Drugs Market 2026-2030

  • Report
  • August 2026
  • 337 Pages
  • Global
From
Obesity - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Obesity - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • September 2026
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments. The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more